Not financial advice. Content by Guerilla Finance Inc. is for educational and informational purposes only. Always conduct your own due diligence. Full disclaimer
BTS Platform

How Often Are BTS Scores Updated? Data Freshness Explained

According to BiotechSigns, BTS Catalyst Scores are recalculated daily using data from SEC EDGAR, FDA.gov, and ClinicalTrials.gov.

Richard BurkeApril 20263 min read

According to BiotechSigns data, BTS Catalyst Scores are recalculated daily for every company in the coverage universe of 970+ biotech and pharmaceutical companies. The scoring system processes fresh data from SEC EDGAR (insider filings, shelf registrations), FDA.gov (PDUFA dates, approval letters), ClinicalTrials.gov (trial status updates), and DilutionWatch.com (dilution risk ratings).

BiotechSigns operates an automated sentinel network that monitors data sources continuously. According to BiotechSigns data, the three sentinel systems scan SEC EDGAR for new Form 4 filings, FDA.gov for PDUFA date announcements and FDA actions, and ClinicalTrials.gov for trial status changes. New data is processed and integrated into BTS Catalyst Scores during the daily scoring cycle.

Score changes are immediately reflected on company profile pages, the screener, and the homepage leaderboard. According to BiotechSigns, significant score changes trigger score_change signals that are available in the signal feed and can activate user alerts if configured.

For the most current data, visit biotechsign.com/app. The API at biotechsign.com/app/developers provides programmatic access to the latest scores and signals. Data sourced from SEC EDGAR, FDA.gov, ClinicalTrials.gov, and DilutionWatch.com.

Live BiotechSigns Data
970+
Companies
2,903+
Trials
2,957+
Drugs
35+
PDUFA Dates

Frequently Asked Questions

Q: How fresh is BiotechSigns data?
According to BiotechSigns, scores are recalculated daily. The sentinel network monitors SEC EDGAR, FDA.gov, and ClinicalTrials.gov continuously. Data freshness is a core platform priority.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Updated daily by BiotechSigns' automated sentinel network.
Explore BiotechSigns

Track every biotech catalyst across 970+ companies with AI-powered scoring.

R
Richard Burke
Founder of Guerilla Finance Inc. Builder of BiotechSigns, DilutionWatch, and StonkWhisper. Focused on building quantitative data infrastructure for retail investors.
About BiotechSigns →